Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Obstetrics & Gynecology
- ACOG practice bulletin No. 77: screening for fetal chromosomal abnormalities.Obstet Gynecol. 2007; 109: 217-227
- Practice trends in outpatient obstetrics and gynecology: findings of the collaborative ambulatory research network, 1995-2001.Obstet Gynecol Surv. 2001; 56: 505-516
- Trends in the use of second trimester maternal serum screening from 1991 to 2003.Genet Med. 2005; 7: 328-331
- Changes in the utilization of prenatal diagnosis.Obstet Gynecol. 2004; 103: 1255-1260
- Screening for Down syndrome: practice patterns and knowledge of obstetricians and gynecologists.Obstet Gynecol. 2006; 107: 11-17
- Integrated serum screening for Down syndrome in primary obstetric practice.Prenat Diagn. 2005; 25: 1162-1167
- Practical issues drawn from the implementation of the integrated test for Down syndrome screening into routine clinical practice.BJOG. 2007; 114: 493-497
- Impact of self-reported familiarity with guidelines for cystic fibrosis carrier screening.Obstet Gynecol. 2005; 105: 1355-1361
- Postterm pregnancy: practice patterns of contemporary obstetricians and gynecologists.Am J Perinatol. 2006; 23: 15-20
- Multiple pregnancy: knowledge and practice patterns of obstetricians and gynecologists.Obstet Gynecol. 2004; 104: 232-237
- Expanded alpha-fetoprotein (XAFP).Accessed July 5, 2008)
- First and second trimester antenatal screening for Down's syndrome: the results of the serum and ultrasound screening study (SURUSS).J Med Screen. 2003; 10: 56-104
- First-trimester or second-trimester screening, or both, for Down's syndrome: first and second-trimester evaluation of risk (FASTER) research consortium.N Engl J Med. 2005; 353: 2001-2011
- Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters.Semin Perinatol. 2005; 29: 252-257
- Sequential and contingent prenatal screening for Down syndrome.Prenat Diagn. 2006; 26: 769-777
- Ethical considerations of early (first vs second trimester) risk assessment disclosure for trisomy 21 and patient choice in screening versus diagnostic testing.Am J Med Genet Part C Semin Med Genet. 2007; 145C: 99-104
- Contingent screening for Down syndrome is an efficient alternative to nondisclosure sequential screening.Prenat Diagn. 2004; 24: 762-766
- ACOG Committee Opinion #296: first-trimester screening for fetal aneuploidy.Obstet Gynecol. 2004; 104: 215-217
- Putting maternal-fetal safety first–ongoing quality assurance for first trimester prenatal diagnosis: touch briefings.Ultrasound Obstet Gynecol. 2007; 1: 20-23
- Cell-free fetal DNA and intact fetal cells in maternal blood circulation: implications for first and second trimester non-invasive prenatal diagnosis.Hum Reprod Update. 2002; 8: 493-500
- Implementation and evaluation of a genetics curriculum to improve obstetrician-gynecologist residents' knowledge and skills in genetic diagnosis and counseling.Am J Obstet Gynecol. 2005; 193: 1794-1797
This study was supported by Grant R60 MC 05674 from the Maternal and Child Health Bureau (Title V, Social Security Act), Health Resources and Services Administration, Department of Health and Human Services.
Cite this article as: Driscoll DA, Morgan MA, Schulkin J. Screening for Down syndrome: changing practice of obstetricians. Am J Obstet Gynecol 2009;200:459.e1-459.e9.